Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Venmax Drugs and Pharmaceuticals Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
2 users have voted
Option Chain
Analyzes market sentiment, predicts Venmax Drugs and Pharmaceuticals Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Venmax Drugs & Pharm - Integrated Filing (Financial)
-
Venmax Drugs & Pharm - Board Meeting Outcome for Financial Results For The Quarter And Nine Months Ended 31.12.2024.
-
Venmax Drugs & Pharm - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report
-
Venmax Drugs & Pharm - Shareholder Meeting / Postal Ballot-Outcome of EGM
-
Venmax Drugs & Pharm - Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended 31St December 2024.
-
Venmax Drugs & Pharm has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024
-
Venmax Drugs & Pharm - Board Meeting Intimation for Increase In Authorised Capital And Fund Raising Proposal.
-
Venmax Drugs & Pharm - Announcement under Regulation 30 (LODR)-Cessation
Key fundamentals
Evaluate the intrinsic value of Venmax Drugs and Pharmaceuticals Ltd stock
Name | March-24 | March-23 | March-22 | March-21 | March-20 |
---|---|---|---|---|---|
Assets | -0.298 | -0.3624 | -0.591 | -0.4572 | -0.1048 |
Liabilities | -0.298 | -0.3624 | -0.591 | -0.4572 | -0.1048 |
Equity | 5.2389 | 5.2389 | 5.2389 | 5.2389 | 5.2389 |
Gross Profit | -0.1045 | -0.1855 | -0.1273 | -0.3328 | -0.2542 |
Net Profit | 0.0645 | 0.2256 | 1.8462 | -0.1624 | -0.2735 |
Cash From Operating Activities | 0.0022 | -0.0031 | 1.905 | 0.2638 | -0.2794 |
NPM(%) | 0 | 0 | 0 | -96.77 | -57.94 |
Revenue | 0 | 0 | 0 | 0.1678 | 0.4721 |
Expenses | 0.1045 | 0.1855 | 0.1273 | 0.5007 | 0.7264 |
ROE(%) | -9.92 | -34.7 | -284 | 24.99 | 42.08 |
Corporate Action
XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
---|
Peers
Other companies within the same industry or sector that are comparable to Venmax Drugs and Pharmaceuticals Ltd
Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
---|---|---|---|---|---|---|
Albert David Ltd | 809.25 | -0.64 | 11.41 | 13.66 | 1321.50 | 1.42 |
Lotus Eye Hospital and Institute Ltd | 58.19 | 1.50 | 237.75 | 49.77 | 14.01 | 0.88 |
Bharat Immunological and Biologicals Corporation Ltd | 21.32 | -1.30 | 0.00 | 103.33 | -39.50 | 0.00 |
Astec Lifesciences Ltd | 654.90 | -5.39 | 0.00 | 46.92 | -239.30 | 0.00 |
Company Info
Yenkey Drugs and Pharmaceuticals Ltd., was originally incorporated on 28th September, 1988 in the name of Yenkey Medico Drugs Private Limited. The Company has been converted into a public limited company on 3rd Feb'95 in terms of a special resolution passed on 23.01.95 under Section 31(1)/44 of the Companies Act, 1956. Accordingly the Company has obtained a fresh Certificate of Incorporation consequent on the conversion from the Registrar of Companies, Andhra Pradesh vide ref. no. 01-09102 dated 3rd February, 1995. The Company is producing bulk drug intermediates as detailed above and marketing in the domestic markets. The total turnover of the Company is Rs. 89.70 lacs for the year ended March 1994. Now the Company proposes to expand the existing capacity of dye and drug intermediate viz; ECA and diversifying into manufacturing of high value chemicals and bulk drugs viz; Sodium Azide and Vitamin B2 Phosphate. The Company is also proposing to set up a R & D Unit for maintaining high quality control standards of foreign buyers. 2009 -Company has changed its name from Yenkey Drugs and Pharmaceuticals Ltd. to Venmax Drugs & Pharmaceuticals Ltd. --Registered Office of the Company has been shifted from Plot No. 1-B12, 2nd floor, S.V.Co-operative Industrial Estate, Balanagar, Hyderabad - 500 037 to 8-3-319/3, Behind Sarathi Studio, Yellareddyguda, Hyderabad - 500 073. 2013 -Venmax Drugs and Pharmaceuticals Ltd has informed that Registered office has been shifted from "Plot No-35,Shivbagh Colony, Ameerpet, Hyderabad - 16" TO "H.NO 6-3-349/35, Flat No-21B, Dwaraka Avenue, DwarakaPuri Colony, Punjagutta, Hyderabad - 32". 2023 -Acquired Brownfield Hotel in Varanasi Uttar Pradesh and Aloft Bengaluru Whitefield Hotel in Karnataka. 2024 - Launched Raaya by atmosphere in Maldives. -Completed the Acquistion transaction pursuant to which our company directly/ indlrectly acquired - Aloft ORR Bengaluru, Anantara Maldives and Conrad Maldives.
Yenkey Drugs and Pharmaceuticals Ltd., was originally incorporated on 28th September, 1988 in the name of Yenkey Medico Drugs Private Limited. The Company has been converted into a public limited company on 3rd Feb'95 in terms of a special resolution passed on 23.01.95 under Section 31(1)/44 of the Companies Act, 1956. Accordingly the Company has obtained a fresh Certificate of Incorporation consequent on the conversion from the Registrar of Companies, Andhra Pradesh vide ref. no. 01-09102 dated 3rd February, 1995. The Company is producing bulk drug intermediates as detailed above and marketing in the domestic markets. The total turnover of the Company is Rs. 89.70 lacs for the year ended March 1994. Now the Company proposes to expand the existing capacity of dye and drug intermediate viz; ECA and diversifying into manufacturing of high value chemicals and bulk drugs viz; Sodium Azide and Vitamin B2 Phosphate. The Company is also proposing to set up a R & D Unit for maintaining high quality control standards of foreign buyers. 2009 -Company has changed its name from Yenkey Drugs and Pharmaceuticals Ltd. to Venmax Drugs & Pharmaceuticals Ltd. --Registered Office of the Company has been shifted from Plot No. 1-B12, 2nd floor, S.V.Co-operative Industrial Estate, Balanagar, Hyderabad - 500 037 to 8-3-319/3, Behind Sarathi Studio, Yellareddyguda, Hyderabad - 500 073. 2013 -Venmax Drugs and Pharmaceuticals Ltd has informed that Registered office has been shifted from "Plot No-35,Shivbagh Colony, Ameerpet, Hyderabad - 16" TO "H.NO 6-3-349/35, Flat No-21B, Dwaraka Avenue, DwarakaPuri Colony, Punjagutta, Hyderabad - 32". 2023 -Acquired Brownfield Hotel in Varanasi Uttar Pradesh and Aloft Bengaluru Whitefield Hotel in Karnataka. 2024 - Launched Raaya by atmosphere in Maldives. -Completed the Acquistion transaction pursuant to which our company directly/ indlrectly acquired - Aloft ORR Bengaluru, Anantara Maldives and Conrad Maldives.
Read More
Parent Organisation
Venmax Drugs & Pharmaceuticals Ltd.
Founded
28/09/1988
Managing Director
Mr.N Krishnaiah
NSE Symbol
FAQ
The current price of Venmax Drugs and Pharmaceuticals Ltd is
The 52-week high for Venmax Drugs and Pharmaceuticals Ltd is
The market capitalization of Venmax Drugs and Pharmaceuticals Ltd is currently
This value can fluctuate based on stock price movements and changes in the number of shares outstanding.To buy Venmax Drugs and Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Venmax Drugs and Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Venmax Drugs and Pharmaceuticals Ltd shares.
The CEO of Venmax Drugs and Pharmaceuticals Ltd is Mr.N Krishnaiah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.